HomeExpert Team Expert Team

Expert Team

Bringing specialists together to find the most suitable treatment option for every cancer patient.

Expert Team

Bringing specialists together to find the most suitable treatment option for every cancer patient.
Filter Providers By
Expert Team
Filter Providers By
Close
Search for medical departments based on the first letter of pinyin
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
no data

No relevant content available

Explanatory text explanatory text explanatory text

  • 5
  • 6
  • 7
  • 8
  • 9
Filter Providers By
Search for medical departments based on the first letter of pinyin
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Jiang Wenyan
    Jiang Wenyan
    Specializes in interventional therapy for malignant tumors including liver, renal, esophageal, gastric, and cervical cancers, as well as liver metastases; proficient in various modalities such as radiotherapy, chemotherapy, immunotherapy, and biotherapy.
    Profile:
    Fosun Cancer Hospital Guangzhou, Jiang Wenyan, Attending Physician in Oncology Ward 2 at Guangzhou Fosun Chancheng Hospital; graduate of Hunan Medical College. She is proficient in various anti-tumor treatment modalities, including radiotherapy, chemotherapy, immunotherapy, biotherapy, and interventional therapy. She specializes in interventional therapy for malignant tumors such as liver, renal, esophageal, gastric, and cervical cancers, as well as liver metastases, and emphasizes the formulation of personalized, comprehensive treatment plans based on the patient's specific condition.
  • Gong Gao
    Gong Gao
    Expert in the comprehensive and molecular targeted treatment of malignancies such as advanced colorectal cancer, gastrointestinal tumors, and gastric cancer; emphasizes multidisciplinary collaboration and the formulation of personalized treatment plans.
    Profile:
    Fosun Cancer Hospital Guangzhou, Gong Gao, Attending Physician in Oncology Ward 2 at Guangzhou Fosun Chancheng Hospital. With years of experience in oncology, he specializes in comprehensive treatment and molecular targeted therapy for advanced colorectal cancer, gastrointestinal tumors, gastric cancer, and other malignancies. He also possesses extensive experience in the comprehensive treatment of prostate cancer, lung cancer, liver cancer, and renal cancer, emphasizing multidisciplinary collaboration and the development of personalized treatment plans.
  • Wei Biyu
    Wei Biyu
    Specializes in treating intestinal, lung, and liver cancers and managing tumor-induced pleural and peritoneal effusions; proficient in comprehensive treatment modalities including immunotherapy, biotherapy, interventional therapy, and deep hyperthermia.
    Profile:
    Fosun Cancer Hospital Guangzhou, Wei Biyu, Attending Physician in Oncology Ward 2 at Guangzhou Fosun Chancheng Hospital. With 15 years of experience in oncology, she specializes in the diagnosis and comprehensive treatment of solid tumors such as colorectal cancer, lung cancer, and liver cancer, as well as the local treatment of tumor-related pleural and peritoneal effusions. She is proficient in techniques including Iodine-125 seed implantation, minimally invasive interventional procedures, microwave ablation, immunotherapy, and deep hyperthermia.
  • Wu Xingjie
    Wu Xingjie
    Specializes in minimally invasive interventional therapy and radioactive seed implantation for intermediate-to-advanced malignant tumors (including liver, lung, nasopharyngeal, gastric, colorectal, breast, and pancreatic cancers), with a focus on the integration of Traditional Chinese and Western medicine.
    Profile:
    Fosun Cancer Hospital Guangzhou, Wu Xingjie, Chief Physician of Oncology Ward 2 at Guangzhou Fosun Chancheng Hospital; Professor and Master's Supervisor at Guangdong Pharmaceutical University; Director of the Medical Imaging Specialist Physician Training Base. He has long focused on the application of integrated Traditional Chinese and Western Medicine in fields such as interventional radiology and tumor hyperthermia. He specializes in minimally invasive interventional therapy and radioactive seed therapy for mid-to-late-stage malignant tumors, including liver, lung, nasopharyngeal, gastric, colorectal, breast, and pancreatic cancers.
  • Li Yanmei
    Li Yanmei
    Specializes in minimally invasive treatments for lung, liver, breast, gastrointestinal, and gynecological tumors, including arterial embolization, seed implantation, microwave ablation, and cryoablation.
    Profile:
    Fosun Cancer Hospital Guangzhou, Li Yanmei, Attending Physician in Oncology Ward 1 at Guangzhou Fosun Chancheng Hospital. Graduated with a major in Clinical Medicine from Zhaoqing Medical College in 2015; has been engaged in clinical oncology since 2020. Specializes in minimally invasive treatments for lung cancer, liver cancer, breast cancer, and gastrointestinal and gynecological tumors; proficient in techniques such as arterial perfusion and embolization, Iodine-125 seed implantation, and microwave and cryoablation.
no data

No relevant content available

Explanatory text explanatory text explanatory text

  • 5
  • 6
  • 7
  • 8
  • 9

Why Choose Us

  • 26,000+
    Over 26,000 international patient visits from 124 countries and regions.
  • 1,000+
    Over 1,000 cancer patients treated with our sixth-generation CyberKnife.
  • 800+
    Over 800 patients treated with the da Vinci Surgical System since April 2023.
  • 500+
    Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.

Why Choose Us

  • 26,000+
    Over 26,000 international patient visits from 124 countries and regions.
  • 1,000+
    Over 1,000 cancer patients treated with our sixth-generation CyberKnife.
  • 800+
    Over 800 patients treated with the da Vinci Surgical System since April 2023.
  • 500+
    Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.